Michael Gillin
Overview
Explore the profile of Michael Gillin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yu J, Zhang X, Liao L, Li H, Zhu R, Park P, et al.
Med Phys
. 2016 Mar;
43(3):1111-8.
PMID: 26936698
Purpose: To develop methods for evaluation and mitigation of dosimetric impact due to respiratory and diaphragmatic motion during free breathing in treatment of distal esophageal cancers using intensity-modulated proton therapy...
12.
Li Y, Niemela P, Liao L, Jiang S, Li H, Poenisch F, et al.
Med Phys
. 2015 Aug;
42(8):4840-7.
PMID: 26233211
Purpose: To develop a new robust optimization strategy for intensity-modulated proton therapy as an important step in translating robust proton treatment planning from research to clinical applications. Methods: In selective...
13.
Nguyen Q, Ly N, Komaki R, Levy L, Gomez D, Chang J, et al.
Radiother Oncol
. 2015 Jun;
115(3):367-72.
PMID: 26028228
Purpose: We report long-term disease control, survival, and toxicity for patients with locally advanced non-small cell lung cancer prospectively treated with concurrent proton therapy and chemotherapy on a nonrandomized case-only...
14.
Li H, Zhang X, Park P, Liu W, Chang J, Liao Z, et al.
Radiother Oncol
. 2015 Feb;
114(3):367-72.
PMID: 25708992
Background And Purpose: Robust optimization for IMPT takes setup and range uncertainties into account during plan optimization. However, anatomical changes were not prospectively included. The purpose of this study was...
15.
Walker G, Johnson J, Edwards T, Gatilao R, Hayden S, Riley B, et al.
Pract Radiat Oncol
. 2014 Nov;
5(1):21-7.
PMID: 25413430
Background: This study evaluated factors associated with radiation therapy (RT) planning and delivery incidents at a large academic institution. Methods And Materials: The RT incidents (including near-misses) were recorded using...
16.
Kardar L, Li Y, Li X, Li H, Cao W, Chang J, et al.
Pract Radiat Oncol
. 2014 Nov;
4(6):e259-68.
PMID: 25407877
Purpose: The primary aim of this study was to evaluate the impact of the interplay effects of intensity modulated proton therapy (IMPT) plans for lung cancer in the clinical setting....
17.
Grosshans D, Zhu X, Melancon A, Allen P, Poenisch F, Palmer M, et al.
Int J Radiat Oncol Biol Phys
. 2014 Oct;
90(3):540-6.
PMID: 25304948
Purpose: To describe treatment planning techniques and early clinical outcomes in patients treated with spot scanning proton therapy for chordoma or chondrosarcoma of the skull base. Methods And Materials: From...
18.
Chang J, Li H, Zhu X, Liao Z, Zhao L, Liu A, et al.
Int J Radiat Oncol Biol Phys
. 2014 Sep;
90(4):809-18.
PMID: 25260491
Purpose: Intensity modulated proton therapy (IMPT) can improve dose conformality and better spare normal tissue over passive scattering techniques, but range uncertainties complicate its use, particularly for moving targets. We...
19.
Pulliam K, Followill D, Court L, Dong L, Gillin M, Prado K, et al.
J Appl Clin Med Phys
. 2014 Sep;
15(5):4935.
PMID: 25207581
Due to a lack of information regarding the current clinical experience of IMRT QA for a large and varied plan population, we reviewed our patient-specific IMRT quality assurance (QA) results...
20.
Zhu Z, Liu W, Gillin M, Gomez D, Komaki R, Cox J, et al.
Radiat Oncol
. 2014 Jun;
9:108.
PMID: 24886059
Background: We assessed the robustness of passive scattering proton therapy (PSPT) plans for patients in a phase II trial of PSPT for stage III non-small cell lung cancer (NSCLC) by...